Neurocrine Biosciences Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 30, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	11,418	13,349	11,712	10,744	7,105	7,321
Market Cap Growth	-18.60%	13.98%	9.01%	51.23%	-2.96%	-17.01%
Enterprise Value	10,884	12,439	10,969	10,261	6,829	6,972
Last Close Price	114.10	132.80	118.85	111.94	73.88	75.86
PE Ratio	31.30	40.49	51.85	74.32	90.18	21.99
PS Ratio	4.99	5.87	6.86	7.71	7.13	8.56
PB Ratio	4.46	5.34	5.80	6.72	5.88	7.95
P/TBV Ratio	4.51	5.43	5.91	6.90	5.88	7.95
P/FCF Ratio	22.59	24.80	35.80	35.56	34.66	41.15
P/OCF Ratio	21.04	23.21	33.20	33.83	31.50	39.19
EV/Sales Ratio	4.82	5.47	6.43	7.37	6.85	8.15
EV/EBITDA Ratio	20.48	21.11	29.14	41.44	35.51	25.37
EV/EBIT Ratio	23.93	22.09	30.71	44.04	37.38	26.04
EV/FCF Ratio	21.53	23.11	33.53	33.96	33.32	39.19
Debt / Equity Ratio	0.16	0.19	0.19	0.15	0.32	0.37
Debt / EBITDA Ratio	0.76	0.76	0.99	0.94	1.88	1.19
Debt / FCF Ratio	0.81	0.89	1.19	0.81	1.89	1.90
Asset Turnover	0.69	0.68	0.67	0.67	0.60	0.69
Inventory Turnover	17.15	15.99	16.48	14.85	11.71	12.59
Quick Ratio	2.89	3.06	2.25	2.49	3.65	5.14
Current Ratio	3.38	3.40	2.45	2.70	3.96	5.45
Return on Equity (ROE)	14.96%	14.16%	12.68%	10.03%	7.17%	46.20%
Return on Assets (ROA)	8.66%	10.46%	8.78%	7.01%	6.82%	13.46%
Return on Invested Capital (ROIC)	16.07%	22.51%	22.75%	17.26%	19.95%	54.61%
Return on Capital Employed (ROCE)	14.90%	18.20%	15.20%	13.60%	11.40%	21.20%
Earnings Yield	3.19%	2.47%	1.93%	1.35%	1.11%	4.55%
FCF Yield	4.43%	4.03%	2.79%	2.81%	2.89%	2.43%
Buyback Yield / Dilution	1.30%	-2.67%	-2.12%	-1.02%	-0.10%	-2.19%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.